Health officials in China are investigating a batch of blood plasma treatments that were reportedly infected with HIV.
China’s National Health Commission released a statement on Tuesday instructing “medical institutions across the country” to stop using a batch of human immunoglobulin distributed by Shanghai Xinxing Pharmaceutical after it received reports of positive HIV tests. Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.